While the threat of U.S. import tariffs prompted a surge in drug production last year, that output is slated to slow across multiple geographies in 2026. | While the threat of U.S. import tariffs ...

In today’s Pharmaceutical Executive Daily, tariff uncertainty triggers a short-term surge in pharmaceutical manufacturing ...

HANGZHOU, ZHEJIANG, CHINA, January 16, 2026 /EINPresswire.com/ -- The pharmaceutical industry is undergoing a period of ...

THE Philippine Chamber of Pharmaceutical Industry (PCPI) has expressed strong support for the Food and Drug Administration’s ...

Manufacturers are pushing for higher prices overseas, but face political and economic resistance.

Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...

While there were outliers, Marston said a major chunk of the investments are concentrated in a few key hubs: Pennsylvania and ...

USP is developing digital reference standards to integrate into modern digital environments, enhancing regulatory confidence ...

Economist David C. Datelle says the pharmaceutical industry's prices have less to do with innovation than with corporate ...

In the age of AI, I believe that pharmaceutical companies must earn influence through trust, personalized engagement and ...

DOVER, DE, UNITED STATES, January 15, 2026 /EINPresswire.com/ -- The safety of parenteral medicines and medical devices ...

Katalyze AI today announced the launch of Katalyst, an AI agent purpose-built for pharmaceutical manufacturing. Designed for ...